Antisense depletion of RIα subunit of protein kinase A induces apoptosis and growth arrest in human breast cancer cells

Rakesh K. Srivastava, Aparna R. Srivastava, Yun Gyu Park, Sudhir Agrawal, Yoon S. Cho-Chung

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

In recent years, several laboratories have explored the possibility of using antisense oligodeoxynucleotides for specific manipulation of gene expression leading to cancer treatment. The enhanced expression of the RIα subunit of cyclic AMP-dependent protein kinase type I (PKA-I) has been correlated with cancer cell growth. In the present study, the effects of an antisense oligodeoxynucleotide targeted against RIα subunit of PKA-I on growth inhibition and apoptosis in MDA-MB-231 human breast cancer cells were investigated. The growth inhibitory effects of RIα antisense oligodeoxynucleotide correlated with a decrease in the RIα mRNA and protein levels. The growth inhibition was accompanied by changes in the cell cycle phase distribution, cell morpbology, cleavage of poly (ADP-ribose) polymerase (PARP), and appearance of apoptotic nuclei. By comparison, mismatched control oligodeoxynucleotide had no effect. On the basis of these results, it can be suggested that the RIα antisense oligodeoxynucleotide, which efficiently depletes the growth stimulatory RIα and induces apoptosis/differentiation, could be used as a therapeutic agent for breast cancer treatment.

Original languageEnglish
Pages (from-to)97-107
Number of pages11
JournalBreast Cancer Research and Treatment
Volume49
Issue number2
DOIs
Publication statusPublished - 1998 Jan 1
Externally publishedYes

Fingerprint

Oligodeoxyribonucleotides
Cyclic AMP-Dependent Protein Kinases
Apoptosis
Breast Neoplasms
Growth
Cyclic AMP-Dependent Protein Kinase Type I
Poly(ADP-ribose) Polymerases
Protein Kinases
Neoplasms
Cell Cycle
Gene Expression
Messenger RNA
Proteins

Keywords

  • Antisense
  • Apoptosis
  • Protein kinase A

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Antisense depletion of RIα subunit of protein kinase A induces apoptosis and growth arrest in human breast cancer cells. / Srivastava, Rakesh K.; Srivastava, Aparna R.; Park, Yun Gyu; Agrawal, Sudhir; Cho-Chung, Yoon S.

In: Breast Cancer Research and Treatment, Vol. 49, No. 2, 01.01.1998, p. 97-107.

Research output: Contribution to journalArticle

Srivastava, Rakesh K. ; Srivastava, Aparna R. ; Park, Yun Gyu ; Agrawal, Sudhir ; Cho-Chung, Yoon S. / Antisense depletion of RIα subunit of protein kinase A induces apoptosis and growth arrest in human breast cancer cells. In: Breast Cancer Research and Treatment. 1998 ; Vol. 49, No. 2. pp. 97-107.
@article{89426d62f6344fba8ea8507c3caca169,
title = "Antisense depletion of RIα subunit of protein kinase A induces apoptosis and growth arrest in human breast cancer cells",
abstract = "In recent years, several laboratories have explored the possibility of using antisense oligodeoxynucleotides for specific manipulation of gene expression leading to cancer treatment. The enhanced expression of the RIα subunit of cyclic AMP-dependent protein kinase type I (PKA-I) has been correlated with cancer cell growth. In the present study, the effects of an antisense oligodeoxynucleotide targeted against RIα subunit of PKA-I on growth inhibition and apoptosis in MDA-MB-231 human breast cancer cells were investigated. The growth inhibitory effects of RIα antisense oligodeoxynucleotide correlated with a decrease in the RIα mRNA and protein levels. The growth inhibition was accompanied by changes in the cell cycle phase distribution, cell morpbology, cleavage of poly (ADP-ribose) polymerase (PARP), and appearance of apoptotic nuclei. By comparison, mismatched control oligodeoxynucleotide had no effect. On the basis of these results, it can be suggested that the RIα antisense oligodeoxynucleotide, which efficiently depletes the growth stimulatory RIα and induces apoptosis/differentiation, could be used as a therapeutic agent for breast cancer treatment.",
keywords = "Antisense, Apoptosis, Protein kinase A",
author = "Srivastava, {Rakesh K.} and Srivastava, {Aparna R.} and Park, {Yun Gyu} and Sudhir Agrawal and Cho-Chung, {Yoon S.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1023/A:1005905723550",
language = "English",
volume = "49",
pages = "97--107",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Antisense depletion of RIα subunit of protein kinase A induces apoptosis and growth arrest in human breast cancer cells

AU - Srivastava, Rakesh K.

AU - Srivastava, Aparna R.

AU - Park, Yun Gyu

AU - Agrawal, Sudhir

AU - Cho-Chung, Yoon S.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - In recent years, several laboratories have explored the possibility of using antisense oligodeoxynucleotides for specific manipulation of gene expression leading to cancer treatment. The enhanced expression of the RIα subunit of cyclic AMP-dependent protein kinase type I (PKA-I) has been correlated with cancer cell growth. In the present study, the effects of an antisense oligodeoxynucleotide targeted against RIα subunit of PKA-I on growth inhibition and apoptosis in MDA-MB-231 human breast cancer cells were investigated. The growth inhibitory effects of RIα antisense oligodeoxynucleotide correlated with a decrease in the RIα mRNA and protein levels. The growth inhibition was accompanied by changes in the cell cycle phase distribution, cell morpbology, cleavage of poly (ADP-ribose) polymerase (PARP), and appearance of apoptotic nuclei. By comparison, mismatched control oligodeoxynucleotide had no effect. On the basis of these results, it can be suggested that the RIα antisense oligodeoxynucleotide, which efficiently depletes the growth stimulatory RIα and induces apoptosis/differentiation, could be used as a therapeutic agent for breast cancer treatment.

AB - In recent years, several laboratories have explored the possibility of using antisense oligodeoxynucleotides for specific manipulation of gene expression leading to cancer treatment. The enhanced expression of the RIα subunit of cyclic AMP-dependent protein kinase type I (PKA-I) has been correlated with cancer cell growth. In the present study, the effects of an antisense oligodeoxynucleotide targeted against RIα subunit of PKA-I on growth inhibition and apoptosis in MDA-MB-231 human breast cancer cells were investigated. The growth inhibitory effects of RIα antisense oligodeoxynucleotide correlated with a decrease in the RIα mRNA and protein levels. The growth inhibition was accompanied by changes in the cell cycle phase distribution, cell morpbology, cleavage of poly (ADP-ribose) polymerase (PARP), and appearance of apoptotic nuclei. By comparison, mismatched control oligodeoxynucleotide had no effect. On the basis of these results, it can be suggested that the RIα antisense oligodeoxynucleotide, which efficiently depletes the growth stimulatory RIα and induces apoptosis/differentiation, could be used as a therapeutic agent for breast cancer treatment.

KW - Antisense

KW - Apoptosis

KW - Protein kinase A

UR - http://www.scopus.com/inward/record.url?scp=0031595777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031595777&partnerID=8YFLogxK

U2 - 10.1023/A:1005905723550

DO - 10.1023/A:1005905723550

M3 - Article

VL - 49

SP - 97

EP - 107

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -